Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

BACKGROUND: The loss of chloroquine (CQ) effectiveness has led to its withdrawal from national policies as a first-line treatment for uncomplicated malaria in several endemic countries, such as the Democratic Republic of Congo (DRC). The K76T mutation on the pfcrt gene has been identified as a marke...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Malar J
Autori principali: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Likwela, Joris L., De Mol, Patrick, Okitolonda, Emile W., Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085146/
https://ncbi.nlm.nih.gov/pubmed/32197607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03192-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi